A Smartphone App for Women With Primary Dysmenorrhea (smartAID)
Primary Purpose
Primary Dysmenorrhea
Status
Unknown status
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Self-care information feature
Self-acupressure feature
Sponsored by
About this trial
This is an interventional prevention trial for Primary Dysmenorrhea focused on measuring mHealth, dysmenorrhea, acupressure, self-management, self-care
Eligibility Criteria
Inclusion Criteria:
- Female, aged 18-34 years
- Dysmenorrhea, defined as self-reported menstrual cramps or pain during every menstrual cycle which started during the teenage years
- No prior history of a gynecological disease that is known to be a reason for the dysmenorrhea
- Not more than 5 days with menstrual pain outside the menstrual period itself
- Menstruation within the last six weeks and a cycle length of 3 to 6 weeks
- Moderate or severe pain, defined as a score equal to or higher than 6 on a numeric rating scale (NRS, 0 to 10) for the worst pain intensity during the last menstruation
- Informed consent
- Possession of an iPhone
- Willingness and ability to input and share anonymous data through the study app
- The willingness to see a doctor when 1) pain is getting worse than usual, 2) pain medication is not helping, and 3) when the pain is still present well before or well after the period.
Exclusion Criteria:
- Known pregnancy
- Pregnancy already planned for the forthcoming 12 months
Sites / Locations
- Charité - Universitätsmedizin BerlinRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Active Comparator
Active Comparator
Arm Label
Complete app
Control intervention I
Control intervention II
Arm Description
198 women with primary dysmenorrhea who receive an app which includes a self-care information feature and a self-acupressure feature.
198 women with primary dysmenorrhea who receive an app for menstrual pain which includes the self-care information feature, but not the self-acupressure feature.
198 women with primary dysmenorrhea who receive an app for menstrual pain which includes the self-acupressure feature, but not the self-care information feature.
Outcomes
Primary Outcome Measures
Mean pain intensity on the days with pain
The mean pain intensity on the days with pain during the 6th menstruation after randomization using a numerical rating scale (NRS; 0=no pain; 10=strongest pain imaginable).
Secondary Outcome Measures
Mean pain intensity on the days with pain
The mean pain intensity on the days with pain during the menstruation 1 to 5 and 7 to 12 after randomization using a numerical rating scale (NRS; 0=no pain; 10=strongest pain imaginable).
Responder
Responder defined as having at least 50% pain reduction on the days with pain
Number of days with pain (duration of pain)
Number of days participants reported pain.
Days with absence from work, training, or studies
Days with absence from work or education because of menstrual pain during previous period.
Days with pain medication
Days with intake of pain medication for menstrual pain during each menstruation
Adverse reaction
Characteristics of adverse reaction
Severe adverse events
Characteristics and duration of severe adverse events
Frequency of acupressure application
Number of times acupressure was applied during each cycle
User satisfaction
User's satisfaction with app guided activity (NRS; 0=totally unsatisfied; 6=very satisfied)
Full Information
NCT ID
NCT03432611
First Posted
January 18, 2018
Last Updated
July 30, 2019
Sponsor
Charite University, Berlin, Germany
Collaborators
University of Zurich
1. Study Identification
Unique Protocol Identification Number
NCT03432611
Brief Title
A Smartphone App for Women With Primary Dysmenorrhea
Acronym
smartAID
Official Title
Evaluation of a Smartphone Application for Self Care for Women With Menstrual Pain (Primary Dysmenorrhea): a Randomized Trial
Study Type
Interventional
2. Study Status
Record Verification Date
July 2019
Overall Recruitment Status
Unknown status
Study Start Date
February 19, 2018 (Actual)
Primary Completion Date
September 2020 (Anticipated)
Study Completion Date
March 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Charite University, Berlin, Germany
Collaborators
University of Zurich
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
With a randomized, pragmatic study the effectiveness of a smartphone app for menstrual pain in 18-34-year-old women with primary dysmenorrhea will be investigated.
Detailed Description
Smartphone apps may be useful to guide and support individuals in self-management strategies. Primary dysmenorrhea is a very common problem for women. With a randomized, pragmatic study the investigators aim to evaluate whether a smartphone app for women with menstrual pain is effective in reducing menstrual pain in 18-34-year-old women with primary dysmenorrhea. For this the investigators compare the complete smartphone app with two control versions of this app. The complete app provides evidence-based self-care information and instructions for self-acupressure in menstrual pain, the control intervention I includes self-care information, but no instructions for self-acupressure, and control intervention II includes instructions for self-acupressure, but no self-care information. The investigators aim to observe 594 women with primary dysmenorrhea over 12 menstruation cycles. The primary outcome is the mean pain intensity on the days with pain during the 6th menstruation after randomization using a numerical rating scale (NRS; 0=no pain; 10=strongest pain imaginable). Women are eligible when they suffer from primary dysmenorrhea, are between 18 and 34 years old, not pregnant and do not plan to be pregnant within the next 12 months.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Primary Dysmenorrhea
Keywords
mHealth, dysmenorrhea, acupressure, self-management, self-care
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
randomized, three-armed pragmatic study
Masking
None (Open Label)
Allocation
Randomized
Enrollment
594 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Complete app
Arm Type
Experimental
Arm Description
198 women with primary dysmenorrhea who receive an app which includes a self-care information feature and a self-acupressure feature.
Arm Title
Control intervention I
Arm Type
Active Comparator
Arm Description
198 women with primary dysmenorrhea who receive an app for menstrual pain which includes the self-care information feature, but not the self-acupressure feature.
Arm Title
Control intervention II
Arm Type
Active Comparator
Arm Description
198 women with primary dysmenorrhea who receive an app for menstrual pain which includes the self-acupressure feature, but not the self-care information feature.
Intervention Type
Other
Intervention Name(s)
Self-care information feature
Intervention Description
The self-care feature offers information on self-care for menstrual pain. The following topics are shown: exercise, dietary supplementation, heating pad/hot water bottle, yoga, and information on when to consult a doctor and how primary dysmenorrhoea is often treated. Notifications from the app which can be deactivated remind women of surveys and activities.
Intervention Type
Other
Intervention Name(s)
Self-acupressure feature
Intervention Description
The acupressure feature offers detailed written and multimedia descriptions of an acupressure used for menstrual pain. Three acupressure points are described, which should be massaged bilaterally twice a day up to five times a day on the 5 days before menstruation and during menstruation. Each point should be massaged for 2 minutes. A timer for the acupressure and notifications from the app which can be deactivated remind women of surveys and acupressure.
Primary Outcome Measure Information:
Title
Mean pain intensity on the days with pain
Description
The mean pain intensity on the days with pain during the 6th menstruation after randomization using a numerical rating scale (NRS; 0=no pain; 10=strongest pain imaginable).
Time Frame
Daily during the 6th menstruation after randomization
Secondary Outcome Measure Information:
Title
Mean pain intensity on the days with pain
Description
The mean pain intensity on the days with pain during the menstruation 1 to 5 and 7 to 12 after randomization using a numerical rating scale (NRS; 0=no pain; 10=strongest pain imaginable).
Time Frame
Baseline; daily during menstruation (1st to 5th and 7th to 12th menstrual cycles)
Title
Responder
Description
Responder defined as having at least 50% pain reduction on the days with pain
Time Frame
Daily during menstruation (1st to 12th menstrual cycles)
Title
Number of days with pain (duration of pain)
Description
Number of days participants reported pain.
Time Frame
Daily during menstruation (1st to 12th menstrual cycles)
Title
Days with absence from work, training, or studies
Description
Days with absence from work or education because of menstrual pain during previous period.
Time Frame
Baseline, end of menstruation (1st to 12th menstrual cycles)
Title
Days with pain medication
Description
Days with intake of pain medication for menstrual pain during each menstruation
Time Frame
Daily during menstruation (1st to 12th menstrual cycles)
Title
Adverse reaction
Description
Characteristics of adverse reaction
Time Frame
End of menstruation (1st to 12th menstrual cycles)
Title
Severe adverse events
Description
Characteristics and duration of severe adverse events
Time Frame
End of menstruation (3rd, 6th, 9th, and 12th menstrual cycles)
Title
Frequency of acupressure application
Description
Number of times acupressure was applied during each cycle
Time Frame
5 days before menstruation and during menstruation (1st to 12th menstrual cycles)
Title
User satisfaction
Description
User's satisfaction with app guided activity (NRS; 0=totally unsatisfied; 6=very satisfied)
Time Frame
End of menstruation (1st to 12th menstrual cycles)
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
Women with menstrual pain
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
34 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Female, aged 18-34 years
Dysmenorrhea, defined as self-reported menstrual cramps or pain during every menstrual cycle which started during the teenage years
No prior history of a gynecological disease that is known to be a reason for the dysmenorrhea
Not more than 5 days with menstrual pain outside the menstrual period itself
Menstruation within the last six weeks and a cycle length of 3 to 6 weeks
Moderate or severe pain, defined as a score equal to or higher than 6 on a numeric rating scale (NRS, 0 to 10) for the worst pain intensity during the last menstruation
Informed consent
Possession of an iPhone
Willingness and ability to input and share anonymous data through the study app
The willingness to see a doctor when 1) pain is getting worse than usual, 2) pain medication is not helping, and 3) when the pain is still present well before or well after the period.
Exclusion Criteria:
Known pregnancy
Pregnancy already planned for the forthcoming 12 months
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Daniel Pach, MD
Phone
004930450529068
Email
daniel.pach@charite.de
First Name & Middle Initial & Last Name or Official Title & Degree
Iris Bartsch
Phone
004930450529132
Email
iris.bartsch@charite.de
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Claudia M. Witt, MD
Organizational Affiliation
Charite University, Berlin, Germany
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Daniel Pach, MD
Organizational Affiliation
Charite University, Berlin, Germany
Official's Role
Principal Investigator
Facility Information:
Facility Name
Charité - Universitätsmedizin Berlin
City
Berlin
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Daniel Pach, MD
Phone
030450529027
Email
luna-studie@charite.de
Email
luna-studie@charite.de
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
32058976
Citation
Wang J, Rogge AA, Armour M, Smith CA, D'Adamo CR, Pischke CR, Yen HR, Wu MY, More AOO, Witt CM, Pach D. International ResearchKit App for Women with Menstrual Pain: Development, Access, and Engagement. JMIR Mhealth Uhealth. 2020 Feb 11;8(2):e14661. doi: 10.2196/14661.
Results Reference
derived
Learn more about this trial
A Smartphone App for Women With Primary Dysmenorrhea
We'll reach out to this number within 24 hrs